 CAMBRIDGE, Mass., Sept. 07, 2021 GLOBE NEWSWIRE -- Evelo Biosciences, Inc. Nasdaq:EVLO, a clinical stage biotechnology company developing a new modality of orally delivered medicines, today announced the appointment of Iain McInnes, M.B.Ch.B, Ph.D., to its Board of Directors. 